Side effects at your second Wegovy dose: what changes at 0.5mg

Step 1: the first few days after your 0.5mg injection

The second dose of Wegovy is 0.5mg, injected once weekly after at least four weeks on the 0.25mg starter pen. If you are curious about exactly how that schedule works, the 0.5mg second dose explained page covers the mechanics. For most people, the days immediately after this step-up are the most unsettled. Nausea tends to arrive within a few hours of the injection and can last a day or two. Some people notice loose stools or a heavier sense of fullness after even small meals. Fatigue, mild headache and a general sense of queasiness are also reported, especially in the morning.

The reason this happens is straightforward: the 0.25mg starter dose was chosen specifically to let your body begin adjusting; at 0.5mg there is meaningfully more receptor activity, and your gut notices. The Wegovy overview explains the mechanism in more detail if you want the background. Practically speaking, eating smaller portions than usual, avoiding fatty or rich foods in the first few days, and staying well hydrated all reduce the intensity. Ginger tea, cold food and eating slowly help many people. These are not workarounds for a problem, they are just sensible ways to work with what the medicine is doing.

Worth knowing: a common misconception is that side effects at this step mean something has gone wrong, or that you are reacting badly. In clinical trials reviewed by the NHS, GI symptoms at dose increases were the norm, not the exception, and the majority resolved within one to two weeks. Discomfort at 0.5mg does not predict how you will feel at higher doses.

Step 2: symptoms that tend to settle, and the timeline to expect

By days seven to ten after your 0.5mg injection, most people find nausea has reduced considerably. The body's adjustment is real, not a matter of mind over matter. The experience at 1mg tends to echo this pattern: a brief intensification after the step-up, then a return to baseline. That rhythm repeats through the titration schedule.

The NHS medicines page for semaglutide lists the common side effects at each stage and is worth reading alongside your Patient Information Leaflet. Common effects that often settle with time include: nausea, vomiting, diarrhoea, constipation, indigestion, burping, bloating, headache and dizziness. Injection-site reactions (mild redness or tenderness where you inject) are also reported and usually resolve quickly. Rotating your injection site between the abdomen, thigh and upper arm reduces skin irritation over time.

If you are finding 0.5mg consistently difficult to tolerate after two weeks, that is a conversation for your prescriber, not something to push through alone. Some people stay at a dose longer before stepping up; there is no clinical prize for rushing the schedule. The full Wegovy dose schedule sets out the titration pathway if you want to plan ahead.

Step 3: side effects that need medical attention, not patience

Most of what happens at 0.5mg is uncomfortable rather than dangerous. But some symptoms should not be waited out. In January 2026, the MHRA's Drug Safety Update on GLP-1 medicines specifically highlighted acute pancreatitis: seek urgent medical help for severe, persistent stomach pain, particularly pain that radiates to the back, with or without vomiting. That symptom pattern is not typical nausea; it is a signal to act quickly.

Other symptoms that warrant same-day contact with a doctor or NHS 111: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat), significant dehydration from repeated vomiting or diarrhoea, gallbladder-type pain (severe pain in the upper right abdomen), and any sudden changes in vision. The side effects seen at higher maintenance doses overlap with these, but the principle holds at every step: when in doubt, get checked. You can also report unexpected reactions through the Yellow Card scheme, your report genuinely contributes to the UK's ongoing safety monitoring of these medicines.

For context on how the side-effect picture compares across the dose ladder, the 1.7mg side effects page is a useful read once you are further along. And if you have questions about how our prescribers approach the 0.5mg step specifically, speak to our prescribers as part of a free consultation, side-effect risk and suitability are central to every clinical review, not an afterthought.